| GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome DC West, D Pan, EY Tonsing-Carter, KM Hernandez, CF Pierce, SC Styke, ... Molecular Cancer Research 14 (8), 707-719, 2016 | 97 | 2016 |
| Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer DC West, M Kocherginsky, EY Tonsing-Carter, DN Dolcen, DJ Hosfield, ... Clinical Cancer Research 24 (14), 3433-3446, 2018 | 65 | 2018 |
| Selective glucocorticoid receptor modulators (SGRMs) delay castrate-resistant prostate cancer growth J Kach, TM Long, P Selman, EY Tonsing-Carter, MA Bacalao, RR Lastra, ... Molecular cancer therapeutics 16 (8), 1680-1692, 2017 | 61 | 2017 |
| Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association E Tonsing-Carter, KM Hernandez, CR Kim, RV Harkless, A Oh, KR Bowie, ... Breast Cancer Research 21, 1-15, 2019 | 47 | 2019 |
| Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist H Wang, S Cai, BJ Bailey, MR Saadatzadeh, J Ding, E Tonsing-Carter, ... Journal of neurosurgery 126 (2), 446-459, 2017 | 45 | 2017 |
| Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model E Tonsing-Carter, BJ Bailey, MR Saadatzadeh, J Ding, H Wang, AL Sinn, ... Molecular cancer therapeutics 14 (12), 2850-2863, 2015 | 44 | 2015 |
| Human Cancer Models Initiative (HCMI): A community resource of next-generation cancer models and associated data E Tonsing-Carter, R Agarwal, CW Kyi, J Perez-Mayoral, CT Soria, ... Cancer Research 83 (7_Supplement), 4681-4681, 2023 | 1 | 2023 |
| NCI office of cancer genomics supports multidisciplinary genomics research initiatives to advance precision oncology CW Kyi, PC Birriel, TM Davidsen, ML Ferguson, P Gesuwan, NB Griner, ... Cancer Research 80 (16_Supplement), 5862-5862, 2020 | 1 | 2020 |
| Glucocorticoid receptor (GR)-mediated activation of cyclic-adenosine monophosphate (cAMP) pathway gene expression following androgen receptor (AR) antagonism of prostate cancer TM Long, EY Tonsing-Carter, WC Chan, DV Griend, SD Conzen, ... Cancer Research 78 (13_Supplement), 944-944, 2018 | 1 | 2018 |
| 860. Outcome of Mechanical Thrombectomy in the Elderly for the Treatment of Acute Ischemic Stroke PC Gerszten, E Paschel, R Grandhi, D Okonkwo, A Kanter, YF Chang, ... Journal of Neurosurgery 123 (2), A479-A541, 2015 | 1 | 2015 |
| Blockade of MDM2-mediated signaling in context of DNA damage increases E2F1 expression and enhances cell death in triple-negative breast cancer cells. E Tonsing-Carter, HE Shannon, BJ Bailey, LD Mayo, KE Pollok Cancer Research 73 (8_Supplement), 4639-4639, 2013 | 1 | 2013 |
| NCI Office of Cancer Genomics: Multidisciplinary genomic research initiatives drive discoveries towards the clinic CW Kyi, PC Birriel, TM Davidsen, ML Ferguson, P Gesuwan, NB Griner, ... Cancer Research 81 (13_Supplement), 2224-2224, 2021 | | 2021 |
| NCI Office of Cancer Genomics: Promoting multidisciplinary research to translate findings into the clinic and advance precision oncology CW Kyi, PC Birriel, TM Davidsen, ML Ferguson, P Gesuwan, NB Griner, ... Cancer Research 79 (13_Supplement), 4341-4341, 2019 | | 2019 |
| Combined androgen and glucocorticoid receptor (AR/GR) activity drives TNBC progression DN Dolcen, E Tonsing-Carter, R Harkless, C Kim, K Bowie, G Fleming, ... Cancer Research 78 (13_Supplement), 2541-2541, 2018 | | 2018 |
| Modulating glucocorticoid receptor function in breast and prostate cancer E Tonsing-Carter, T Long, DC West, R Harkless, DN Dolcen, D Hosfield, ... Endocrine Abstracts 54, 2018 | | 2018 |
| Glucocorticoid receptor inhibits ER-mediated pro-proliferative gene expression E Tonsing-Carter, CR Kim, KM Hernandez, KR Bowie, DC West, ... Endocrine Abstracts 54, 2018 | | 2018 |
| 973. Plasticity of motor representations in patients with brain lesions: a navigated TMS study E Green, A Benton, HE James, T MacGregor, D Childers Jr, RWJ Ryan, ... Journal of Neurosurgery 126 (4), A1375-A1444, 2017 | | 2017 |
| Improvement of Frontline Therapy for GBM by Targeting the DNA Damage Response AA Cohen-Gadol, MR Saadatzadeh, H Wang, B Bailey, J Ding, ... JOURNAL OF NEUROSURGERY 126 (4), A1404-A1404, 2017 | | 2017 |
| Abstract P3-05-09: Glucocorticoid receptor modulation affects ER+ breast cancer cell proliferation E Tonsing-Carter, KR Bowie, DC West, RV Harkless, KM Hernandez, ... Cancer Research 77 (4_Supplement), P3-05-09-P3-05-09, 2017 | | 2017 |
| Inhibition of MDM2 and AKT signaling networks synergize to activate Forkhead box O-class transcription factors and promote cell death in mutant p53 GBM cells MR Saadatzadeh, H Wang, J Ding, BJ Bailey, E Tonsing-Carter, S Cai, ... CANCER RESEARCH 75, 2015 | | 2015 |
Harlan ShannonDept of Pediatrics, IU School of MedicineVerified email at iupui.edu
